Insulin is one of the most important drugs in the history of pharmaceuticals. Since the separation of active insulin from animals by the Canadian doctor Frederick Grant Banting, it has been around for nearly a hundred years and has been continuously upgraded to meet the demand for diabetes. To… Continue Reading After OI388GT terminated the trial, Novo Nordisk deployed oral insulin again, and plans to enter the human clinical clinic within three years.
Just as several large pharmaceutical companies faced patent cliffs several years ago, the next six years, another wave of original research drugs face patent limits. A recent EvaluatePharma report stated that between 2018 and 2024, sales of medicines that are about to lose patent protection amounted to US$250 billion. The… Continue Reading A new wave of patent cliffs arrives, affecting 250 billion US dollars of original research varieties